CLINICAL RELEVANCE OF PLASMA TESTOSTERONE AND PROLACTIN CHANGES IN ADVANCED CANCER OF PROSTATE TREATED WITH DIETHYLSTILBESTROL OR ESTRAMUSTINE PHOSPHATE

被引：12

作者：

MORALES, A

NICKEL, JC

机构：

来源：

UROLOGY | 1985年 / 26卷 / 05期

关键词：

D O I：

10.1016/0090-4295(85)90158-X

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：477 / 481

页数：5

共 28 条

[1] HORMONAL PATTERN IN PROSTATIC-CANCER .2. CORRELATION WITH PRIMARY RESPONSE TO ENDOCRINE TREATMENT [J].

ADLERCREUTZ, H ;

RANNIKKO, S ;

KAIRENTO, AL ;

KARONEN, SL .

ACTA ENDOCRINOLOGICA, 1981, 98 (04) :634-640

[2]

Andersson L, 1980, Scand J Urol Nephrol Suppl, V55, P143

[3]

ARAGONA C, 1975, ENDOCRINOLOGY, V97, P51

[4] TREATMENT OF STAGE D HORMONE-RESISTANT CARCINOMA OF THE PROSTATE WITH ESTRAMUSTINE PHOSPHATE [J].

BENSON, RC ;

WEAR, JB ;

GILL, GM .

JOURNAL OF UROLOGY, 1979, 121 (04) :452-454

[5]

BERRY WR, 1979, CANCER, V44, P763, DOI 10.1002/1097-0142(197908)44:2<763::AID-CNCR2820440251>3.0.CO

[6]

2-5

[7] PLASMA PROLACTIN, GH, LH, FSH, TSH AND TESTOSTERONE DURING TREATMENT OF PROSTATIC CARCINOMA WITH ESTROGENS [J].

BOYNS, AR ;

COLE, EN ;

PHILLIPS, ME ;

HILLIER, SG ;

CAMERON, EHD ;

GRIFFITHS, K ;

SHAHMANESH, M ;

FENELEY, RCL ;

HARTOG, M .

EUROPEAN JOURNAL OF CANCER, 1974, 10 (07) :445-449

[8]

BOYNS AR, 1972, PROLACTIN CARCINOGEN, P207

[9]

Edsmyr F, 1980, Scand J Urol Nephrol Suppl, V55, P139

[10]

FARNSWORTH W E, 1977, Urology, V10, P33, DOI 10.1016/0090-4295(77)90034-6

← 1 2 3 →